Skip to content
naulon
Not checkedNot checked for notices yet.

Editorial: Anti-Inflammatory Agents in the Context of Age-Related Cardiometabolic Disease: Ethnopharmacological Perspectives

Somasundaram Arumugam, Wawaimuli Arozal, Koji Ikeda

Frontiers in Pharmacology · 2022

doi:10.3389/fphar.2022.923287 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Ethnopharmacological PerspectivesAging is a normal physiological process altering cell function largely through cellular senescence, but sometimes accelerated aging and/or excess accumulation of senescent cells in individuals may lead to several complications affecting the quality of life.One such complication is cardiometabolic disease, which is commonly seen in the elderly and is a global burden, causing health and economic problems.Though various treatment strategies are made available to manage the cardiometabolic diseases such as atherosclerosis, angina pectoris, and myocardial infarction (MI), etc., traditional systems of medicine play a major role in their treatment in various countries, such as Ayurveda, traditional Chinese medicine (TCM), Japanese Kampo medicine, Homoeopathy, Unani, and Siddha, etc.The lack of evidence for their beneficial effects as well as their molecular effects urged us to choose this topic.Louisa et al. from the University of Indonesia have performed a systematic review on the role of Moringa oleifera Lam [Moringaceae] in cardiovascular or metabolic disorders, in addition to its high nutritional value.Moringa oleifera Lam. is a native plant of several Asian countries and is reported to provide potential benefits against oxidative stress and inflammation, modulating glucose and lipid metabolism and preventing end-organ damage.They have also covered the importance of altering the gut microbiota in metabolic syndrome in addition to the supporting data for the role of Moringa oleifera Lam. on various signaling pathways activated during inflammation and oxidative stress.Liu et al. have studied the molecular basis of the effect of ShenLian extract on atherosclerotic plaques in vitro and in vivo.By using the co-culture model, macrophage and smooth muscle cell (SMC) interactions were studied and reported the necessary role of transforming growth factor (TGF)-β in the cross-talk between macrophages and SMC in stabilizing the atherosclerotic plaques.They have reported that ShenLian extract (an herbal decoction consisting of Coptis chinensis Franch.and Panax ginseng C.A.Mey.) could stabilize the vulnerable plaques by increasing plaque collagen and functionally reconstruct the extracellular matrix via increasing TGF-β expression and regulating the STAT3/SOCS3 pathway.Liu et al. and her team reported that the monocyte locomotion inhibitory factor (MLIF), a heat-stable pentapeptide from Entamoeba histolytica, promoted microglia transition toward the M2 phenotype, which contributes to neuronal survival and tissue repair, in vivo and in vitro ischemic stroke model via regulation of eEF1A1/

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.